• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶(MMPs)启动子区域多态性与癌症转移风险的关系:荟萃分析。

Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis.

机构信息

Department of Medical Genetics, College of Basic Medical Sciences, Third Military Medical University, Chongqing, China.

出版信息

PLoS One. 2012;7(2):e31251. doi: 10.1371/journal.pone.0031251. Epub 2012 Feb 14.

DOI:10.1371/journal.pone.0031251
PMID:22348060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3279370/
Abstract

BACKGROUND

A variety of studies have evaluated the associations between polymorphisms in the promoter regions of Matrix metalloproteinases (MMPs) and cancer metastasis. However, the results remain inconclusive. To better understand the roles of MMP polymorphisms in metastasis, we conducted a comprehensive meta-analysis.

METHODS

Electronic databases were searched (from January 2000 to June 2011) for any MMP genetic association studies in metastasis. Overall and subgroup analyses were performed. Odds ratio (OR) and 95% confidence interval (CI) were used to evaluate the associations between MMP polymorphisms and metastasis. Statistical analysis was performed with Review Manager 5.0 and STATA11.0.

RESULTS

Thirty-three studies addressing five MMP polymorphisms were analyzed among 10,516 cancer cases (4,059 metastasis-positive cases and 6,457 metastasis-negative cases). For MMP1 (-1607)1G/2G, genotype 2G/2G increased the overall risk of metastasis under the recessive model (OR = 1.44, 95% CI = 1.05-1.98). In subgroup analysis based on cancer type, associations were found in head/neck and breast cancer under the recessive model, and also in breast cancer under the dominant model. For MMP3 (-1171) 5A/6A, the polymorphism decreased the overall risk of metastasis under two genetic models (recessive: OR = 0.80, 95%CI = 0.64-0.99, dominant: OR = 0.72, 95%CI = 0.56-0.93). The polymorphisms of MMP7 (-181) A/G and MMP9 (-1562) C/T increased metastatic risk. However, no association was observed between MMP2 (-1306) C/T and metastasis.

CONCLUSIONS

Our investigations demonstrate that polymorphisms in the promoter regions of MMP1, 3, 7 and 9 might be associated with metastasis in some cancers. Further studies with large sample size for MMP2 should be conducted.

摘要

背景

多项研究评估了基质金属蛋白酶(MMPs)启动子区域的多态性与癌症转移之间的关系。然而,结果仍不确定。为了更好地理解 MMP 多态性在转移中的作用,我们进行了一项综合荟萃分析。

方法

从 2000 年 1 月至 2011 年 6 月,我们对任何 MMP 遗传关联研究的电子数据库进行了检索(转移中的 MMP 遗传关联研究)。进行了总体和亚组分析。比值比(OR)和 95%置信区间(CI)用于评估 MMP 多态性与转移之间的关系。统计分析使用 Review Manager 5.0 和 STATA11.0 进行。

结果

分析了 10516 例癌症病例(4059 例转移阳性病例和 6457 例转移阴性病例)中的 33 项 MMP 多态性研究。对于 MMP1(-1607)1G/2G,在隐性模型下,基因型 2G/2G 增加了转移的总体风险(OR=1.44,95%CI=1.05-1.98)。在基于癌症类型的亚组分析中,在隐性模型下发现了头颈部和乳腺癌的相关性,在显性模型下也发现了乳腺癌的相关性。对于 MMP3(-1171)5A/6A,该多态性在两种遗传模型下降低了转移的总体风险(隐性:OR=0.80,95%CI=0.64-0.99,显性:OR=0.72,95%CI=0.56-0.93)。MMP7(-181)A/G 和 MMP9(-1562)C/T 的多态性增加了转移的风险。然而,MMP2(-1306)C/T 与转移之间没有关联。

结论

我们的研究表明,MMP1、3、7 和 9 启动子区域的多态性可能与某些癌症的转移有关。对于 MMP2,应该进行具有更大样本量的进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad3a/3279370/1ffad8ed12c2/pone.0031251.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad3a/3279370/d18b58d38d37/pone.0031251.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad3a/3279370/9ad3306392c4/pone.0031251.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad3a/3279370/31007a9844f4/pone.0031251.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad3a/3279370/9b89f7835f8e/pone.0031251.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad3a/3279370/1ffad8ed12c2/pone.0031251.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad3a/3279370/d18b58d38d37/pone.0031251.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad3a/3279370/9ad3306392c4/pone.0031251.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad3a/3279370/31007a9844f4/pone.0031251.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad3a/3279370/9b89f7835f8e/pone.0031251.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad3a/3279370/1ffad8ed12c2/pone.0031251.g005.jpg

相似文献

1
Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis.基质金属蛋白酶(MMPs)启动子区域多态性与癌症转移风险的关系:荟萃分析。
PLoS One. 2012;7(2):e31251. doi: 10.1371/journal.pone.0031251. Epub 2012 Feb 14.
2
Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.目前关于基质金属蛋白酶(MMP)基因中的五个多态性与肺癌风险之间关系的证据:一项荟萃分析。
Gene. 2013 Mar 15;517(1):65-71. doi: 10.1016/j.gene.2012.12.085. Epub 2013 Jan 9.
3
Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.基质金属蛋白酶 1 和 3 启动子区域多态性与癌症风险:50 项病例对照研究的荟萃分析。
Mutagenesis. 2010 Jan;25(1):41-8. doi: 10.1093/mutage/gep041. Epub 2009 Oct 20.
4
Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.基质金属蛋白酶 2、3 和 9 启动子多态性与头颈部癌症风险的荟萃分析。
PLoS One. 2013 Apr 24;8(4):e62023. doi: 10.1371/journal.pone.0062023. Print 2013.
5
Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis.基质金属蛋白酶启动子多态性与消化道癌风险的关联:荟萃分析。
J Cancer Res Clin Oncol. 2013 Sep;139(9):1433-47. doi: 10.1007/s00432-013-1446-9. Epub 2013 May 5.
6
Meta-analysis of associations between four polymorphisms in the matrix metalloproteinases gene and gastric cancer risk.基质金属蛋白酶基因中四种多态性与胃癌风险关联的荟萃分析。
Asian Pac J Cancer Prev. 2014;15(3):1263-7. doi: 10.7314/apjcp.2014.15.3.1263.
7
Meta-analysis of associations between polymorphisms in the promoter regions of matrix metalloproteinases and the risk of colorectal cancer.基质金属蛋白酶启动子区域多态性与结直肠癌风险的关联:荟萃分析
Int J Colorectal Dis. 2011 Sep;26(9):1099-105. doi: 10.1007/s00384-011-1198-4. Epub 2011 May 3.
8
Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.胶原酶-1(MMP1)、基质溶解素-1(MMP3)和明胶酶-B(MMP9)基因多态性在乳腺癌中的协同作用。
PLoS One. 2017 Sep 29;12(9):e0184448. doi: 10.1371/journal.pone.0184448. eCollection 2017.
9
Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma.基质金属蛋白酶1、基质金属蛋白酶3和基质金属蛋白酶7基因启动子的基因多态性与结肠直肠腺瘤风险
BMC Cancer. 2006 Nov 24;6:270. doi: 10.1186/1471-2407-6-270.
10
Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.基质金属蛋白酶 2、7 和 9 启动子多态性与癌症风险关联的荟萃分析。
Mutagenesis. 2010 Jul;25(4):371-9. doi: 10.1093/mutage/geq015. Epub 2010 Apr 1.

引用本文的文献

1
A Case-Control Study on the Association Between and Genetic Polymorphisms and Breast Cancer.一项关于[具体基因名称1]和[具体基因名称2]基因多态性与乳腺癌关联的病例对照研究。 (注:原文中两个基因名称缺失,需补充完整才能准确翻译)
Health Sci Rep. 2025 Jul 28;8(8):e71123. doi: 10.1002/hsr2.71123. eCollection 2025 Aug.
2
Effects of barakol from on neuroblastoma SH-SY5Y cell line: A potential combined therapy with doxorubicin.巴拉科尔对神经母细胞瘤SH-SY5Y细胞系的影响:与阿霉素联合治疗的潜力。
Heliyon. 2024 Jan 19;10(3):e24694. doi: 10.1016/j.heliyon.2024.e24694. eCollection 2024 Feb 15.
3
Association of gene polymorphisms with breast cancer risk: A narrative review.

本文引用的文献

1
Correlation of polymorphism of IL-8 and MMP-7 with occurrence and lymph node metastasis of early stage cervical cancer.白细胞介素-8和基质金属蛋白酶-7基因多态性与早期宫颈癌发生及淋巴结转移的相关性
J Huazhong Univ Sci Technolog Med Sci. 2011 Feb;31(1):114-119. doi: 10.1007/s11596-011-0161-5. Epub 2011 Feb 19.
2
Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer.结直肠癌 TIMP2、MMP2 和 MMP9 基因多态性的临床特征。
J Gastroenterol Hepatol. 2011 Feb;26(2):391-7. doi: 10.1111/j.1440-1746.2010.06504.x.
3
Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects.
基因多态性与乳腺癌风险的关联:一项叙述性综述。
Health Sci Rep. 2023 Oct 13;6(10):e1607. doi: 10.1002/hsr2.1607. eCollection 2023 Oct.
4
Causal relationships between serum matrix metalloproteinases and estrogen receptor-negative breast cancer: a bidirectional mendelian randomization study.血清基质金属蛋白酶与雌激素受体阴性乳腺癌之间的因果关系:一项双向孟德尔随机化研究。
Sci Rep. 2023 May 15;13(1):7849. doi: 10.1038/s41598-023-34200-0.
5
Matrix Metalloproteinase Gene Polymorphisms Are Associated with Breast Cancer in the Caucasian Women of Russia.基质金属蛋白酶基因多态性与俄罗斯白种女性乳腺癌相关。
Int J Mol Sci. 2022 Oct 20;23(20):12638. doi: 10.3390/ijms232012638.
6
Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action.白藜芦醇在乳腺癌治疗中的应用:从细胞作用到作用机制。
Cell Mol Life Sci. 2022 Oct 4;79(11):539. doi: 10.1007/s00018-022-04551-4.
7
The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer.基质金属蛋白酶单核苷酸多态性在乳腺癌临床病理特征中的作用
Biomedicines. 2022 Aug 4;10(8):1891. doi: 10.3390/biomedicines10081891.
8
Head and Neck Squamous Cell Carcinoma: Risk Factors, Molecular Alterations, Immunology and Peptide Vaccines.头颈部鳞状细胞癌:危险因素、分子改变、免疫学与肽疫苗
Int J Pept Res Ther. 2022;28(1):19. doi: 10.1007/s10989-021-10334-5. Epub 2021 Dec 8.
9
Association of Matrix Metalloproteinase-1 Genotypes With Bladder Cancer Risk.基质金属蛋白酶-1 基因型与膀胱癌风险的关联。
In Vivo. 2021 Sep-Oct;35(5):2535-2540. doi: 10.21873/invivo.12535.
10
Contribution of Genotypes to Colorectal Cancer in Taiwan.台湾地区基因型对结直肠癌的影响。
Cancer Genomics Proteomics. 2021 May-Jun;18(3):245-251. doi: 10.21873/cgp.20255. Epub 2021 Apr 23.
超过30000名受试者中基质金属蛋白酶1、2、3和9的多态性与肺癌、乳腺癌和结直肠癌易感性的关系
Int J Cancer. 2009 Sep 15;125(6):1473-8. doi: 10.1002/ijc.24441.
4
The influence of interstitial collagenase-1 genotype polymorphism on colorectal cancer risk in Iranian population.间质胶原酶-1基因多态性对伊朗人群结直肠癌风险的影响。
Cancer Invest. 2008 Oct;26(8):836-42. doi: 10.1080/07357900801953204.
5
A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer.基质金属蛋白酶-1和白细胞介素-8基因启动子中的单核苷酸多态性预示着舌癌的预后不良。
Auris Nasus Larynx. 2008 Sep;35(3):381-9. doi: 10.1016/j.anl.2007.12.002. Epub 2008 Feb 13.
6
Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population.基质金属蛋白酶-1(MMP-1)1G/2G启动子基因多态性在土耳其人群前列腺癌发生中的作用
Urol Int. 2007;79(4):312-5. doi: 10.1159/000109715.
7
Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.基质金属蛋白酶单核苷酸多态性和单倍型可预测乳腺癌进展。
Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6673-80. doi: 10.1158/1078-0432.CCR-07-0884.
8
Functional polymorphisms in the promoter regions of MMP2 and MMP3 are not associated with melanoma progression.基质金属蛋白酶2(MMP2)和基质金属蛋白酶3(MMP3)启动子区域的功能多态性与黑色素瘤进展无关。
J Negat Results Biomed. 2007 Oct 24;6:9. doi: 10.1186/1477-5751-6-9.
9
Matrix metalloproteinase-9-1562C>T polymorphism may increase the risk of lymphatic metastasis of colorectal cancer.基质金属蛋白酶-9-1562C>T多态性可能增加结直肠癌发生淋巴转移的风险。
World J Gastroenterol. 2007 Sep 14;13(34):4626-9. doi: 10.3748/wjg.v13.i34.4626.
10
Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.基质金属蛋白酶-1、-3、-7、-9、-12及纤溶酶原激活物抑制剂-1基因多态性在结直肠癌中的临床意义
J Gastroenterol Hepatol. 2007 Jul;22(7):1064-70. doi: 10.1111/j.1440-1746.2006.04424.x.